WET AMD
Clinical trials for WET AMD explained in plain language.
Never miss a new study
Get alerted when new WET AMD trials appear
Sign up with your email to follow new studies for WET AMD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
One-Shot gene therapy could free wet AMD patients from monthly eye needles
Disease control Recruiting nowThis study tests a single injection of LX102 gene therapy under the retina for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The goal is to see if it can maintain or improve vision better than standard anti-VEGF injections, potentially re…
Matched conditions: WET AMD
Phase: PHASE3 • Sponsor: Innostellar Biotherapeutics Co.,Ltd • Aim: Disease control
Last updated May 26, 2026 09:10 UTC
-
One-Shot gene therapy could replace monthly eye injections for wet AMD
Disease control Recruiting nowThis Phase 3 trial tests a single injection of Ixo-vec gene therapy in 284 people with wet age-related macular degeneration (nAMD). The goal is to see if it can maintain or improve vision as well as standard aflibercept injections, but with fewer treatments needed. Participants r…
Matched conditions: WET AMD
Phase: PHASE3 • Sponsor: Adverum Biotechnologies, Inc. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC